Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Tobacco Control 2006;15:181-188; doi:10.1136/tc.2005.013284
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martiniuk, A L C
Right arrow Search for Related Content
PubMed
Right arrow Articles by Martiniuk, A L C
Related Collections
Right arrow Smoking
Right arrow Health effects of tobacco use
Right arrow Ischemic heart disease
Right arrow Stroke

RESEARCH PAPER

The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions

A L C Martiniuk, C M Y Lee, T H Lam, R Huxley, I Suh, K Jamrozik, D F Gu, M Woodward for the Asia Pacific Cohort Studies Collaboration

Writing Committee, Asia Pacific Cohort Studies Collaboration

Correspondence to:
Alexandra Martiniuk
The George Institute for International Health, PO Box M201, Missenden Road, Camperdown, NSW, 2050, Australia; amartiniuk{at}thegeorgeinstitute.org

Background: Tobacco will soon be the biggest cause of death worldwide, with the greatest burden being borne by low and middle-income countries where 8/10 smokers now live.

Objective: This study aimed to quantify the direct burden of smoking for cardiovascular diseases (CVD) by calculating the population attributable fractions (PAF) for fatal ischaemic heart disease (IHD) and stroke (haemorrhagic and ischaemic) for all 38 countries in the World Health Organization Western Pacific and South East Asian regions.

Design and subjects: Sex-specific prevalence of smoking was obtained from existing data. Estimates of the hazard ratio (HR) for IHD and stroke with smoking as an independent risk factor were obtained from the ~600 000 adult subjects in the Asia Pacific Cohort Studies Collaboration (APCSC). HR estimates and prevalence were then used to calculate sex-specific PAF for IHD and stroke by country.

Results: The prevalence of smoking in the 33 countries, for which relevant data could be obtained, ranged from 28–82% in males and from 1–65% in females. The fraction of IHD attributable to smoking ranged from 13–33% in males and from <1–28% in females. The percentage of haemorrhagic stroke attributable to smoking ranged from 4–12% in males and from <1–9% in females. Corresponding figures for ischaemic stroke were 11–27% in males and <1–22% in females.

Conclusions: Up to 30% of some cardiovascular fatalities can be attributed to smoking. This is likely an underestimate of the current burden of smoking on CVD, given that the smoking epidemic has developed further since many of the studies were conducted.


Abbreviations: APCSC, Asia Pacific Cohort Studies Collaboration; CVD, cardiovascular disease; IHD, ischaemic heart disease; LMIC, low and middle-income countries; PAF, population attributable fractions; HR, hazard ratio; WHO, World Health Organization

Keywords: attributable fraction; ischaemic heart disease; stroke; smoking; Western-Pacific; South-East Asia




This article has been cited by other articles:


Home page
Tobacco ControlHome page
H. Ross, D. V. Trung, and V. X. Phu
The costs of smoking in Vietnam: the case of inpatient care
Tob. Control, December 1, 2007; 16(6): 405 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
G. Hughes
Hygieia
J. Epidemiol. Community Health, September 1, 2006; 60(9): 824 - 824.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.